Elicio Therapeutics, Inc.
ELTX
$2.18
-$0.17-7.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.30% | -18.54% | 5.36% | -20.78% | 544.91% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 415.13% | -41.83% | -66.44% | -80.00% | -88.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 113.11% | -67.45% | -86.42% | -84.63% | -64.24% |
| Total Current Assets | 12.78% | -22.62% | -6.68% | -29.96% | 237.84% |
|
|
|||||
| Total Current Assets | 12.78% | -22.62% | -6.68% | -29.96% | 237.84% |
| Net Property, Plant & Equipment | -19.98% | -19.00% | -17.97% | -17.09% | -16.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.08% | 31.05% | 13.73% | 13.84% | -44.01% |
| Total Assets | 6.10% | -19.38% | -8.22% | -26.32% | 87.48% |
|
|
|||||
| Total Accounts Payable | -78.29% | -93.26% | -35.26% | -83.82% | 266.35% |
| Total Accrued Expenses | 42.77% | 2.51% | -23.62% | 7.44% | 18.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.71% | 12.53% | 12.21% | 11.86% | 11.48% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -7.27% | -36.66% | -29.62% | -27.77% | 30.82% |
|
|
|||||
| Total Current Liabilities | -7.27% | -36.66% | -29.62% | -27.77% | 30.82% |
| Long-Term Debt | 2.12% | -- | -53.04% | -51.00% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -23.26% | -21.42% | -19.80% | -18.40% | -17.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -70.79% | 21.51% | -7.53% | -83.28% | -10.14% |
| Total Liabilities | -15.53% | 25.40% | -38.65% | -57.35% | 59.14% |
|
|
|||||
| Common Stock & APIC | 20.19% | 13.90% | 28.65% | 42.42% | 36.21% |
| Retained Earnings | -17.53% | -19.57% | -20.39% | -25.46% | -33.87% |
| Treasury Stock & Other | -25.45% | 7.48% | 14.77% | 48.58% | 43.30% |
| Total Common Equity | 332.77% | -116.14% | 114.46% | 120.10% | 211.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 332.77% | -116.14% | 114.46% | 120.10% | 211.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 332.77% | -116.14% | 114.46% | 120.10% | 211.02% |
|
|
|||||